Luxury Licensees are Facing Off for the Right to Make and Market Big-Name Eyewear, Fragrances

Luxury Licensees are Facing Off for the Right to Make and Market Big-Name Eyewear, Fragrances

[et_pb_section admin_label=”section”] [et_pb_row admin_label=”row”] [et_pb_column type=”4_4″][et_pb_text admin_label=”Text”]image: Valentino Nowadays, fashion’s buzziest “wars” are often fought on Instagram, whether ...

November 5, 2017 - By TFL

Luxury Licensees are Facing Off for the Right to Make and Market Big-Name Eyewear, Fragrances

Case Documentation

Luxury Licensees are Facing Off for the Right to Make and Market Big-Name Eyewear, Fragrances

[et_pb_section admin_label=”section”] [et_pb_row admin_label=”row”] [et_pb_column type=”4_4″][et_pb_text admin_label=”Text”]
 image: Valentino

image: Valentino

Nowadays, fashion’s buzziest “wars” are often fought on Instagram, whether it be claims of copying or backlash involving allegations of cultural appropriation. Look past this inherently click-able content and you will see a larger, more significant battle underway behind the scenes: one that involves some of the market’s largest manufacturers, which are busy squaring off in an effort to build up billion dollar rosters of big brand names to gain (or maintain) the wildly lucrative title of “leader” in the realms of cosmetics, fragrances, and eyewear.

Some of the key players in this fight are names you may know. There is Coty, L’Oreal, Puig, Perfumania, and Inter Parfums. There is Marcolin and Marchon, and still yet, not to be overlooked, Safilo, and Essilor-Luxottica, to name a few. Even if you do not know these names, if you own a pair of luxury-branded sunglasses or just about any fashion fragrance, you have come in contact with their offerings.

Here’s why: take that Prada Eau de Parfum being stocked by Sephora, for instance, or the Chanel eyewear being offered up on the brand’s website. While these products bear the brands’ names, they were not actually made, marketed, or distributed directly by those brands. Instead, one of the aforementioned companies was responsible for that as part of a big-money licensing deal, one that see the brand

Given the brand names and potential revenues at stake, it does not go unnoticed whenever one of these licenses changes hands. This spring, for instance, L’Oreal announced that it is well on its way to becoming “the world leader in perfumes.” The tipping point? It’s “win” of the Valentino fragrance license.

In May, the Paris-based beauty firm revealed that it will produce fragrances and cosmetics for Italian fashion label Valentino, enhancing its own perfume business roster by scoring a license previously held by fellow cosmetic giant Puig. The latter, a Spanish fashion and fragrance business, currently has dibs on the right to exclusively make, market, and claim profits on fragrances (and in some cases, other beauty products) bearing the Prada, Comme des Garcons, Nina Ricci, Paco Rabanne, Carolina Herrera, Christian Louboutin, and Jean Paul Gaultier names, among others.

L’Oreal’s move to lure Valentino away from Barcelona-based Puig – which announced in early 2010 that it had partnered with the Italian fashion brand as part of “a multi-year worldwide license agreement involving the creation, development and distribution of luxury fine fragrances under the Valentino brand” – is par for the course in this ongoing game of licensor/licensee. But far from merely a small-stakes pastime, the business of licensing is a multi-hundred million dollar per brand power play.

For the uninitiated, these highly lucrative licensing deals see brands trade off the right to use their names and logos in certain goods categories in exchange for oft-hefty royalties, in furtherance of a partnership that sees brands expanding into previously untapped markets.

For example, in April 2017, Coty announced that it would pay Burberry a whopping $225 million – plus an undisclosed sum of recurring royalties – for the right to use the British brand’s name on fragrances and cosmetics in the U.S. The heft of the revenue earned on the sale of such goods, minus the agreed-up royalty fees, will be recorded on Coty’s books.

The same goes for Gucci, Prada, Miu Miu, Calvin Klein, Marc Jacobs, Balenciaga, Alexander McQueen, Tiffany & Co., and Jil Sander fragrances, for which Coty maintains the exclusive rights.

Before that, footwear brand Christian Louboutin looked to Puig “to bring [its] beauty business to the next level while understanding and protecting [its] DNA and keeping [its] existing high positioning in the market.”

While the initiation of such licensing deals is proving to be as headline-making as traditional brand acquisitions, unlike when a conglomerate buys a brand (a deal that does not tend to come with an expiration date from the outset), licensing deals are limited in terms of duration, making for a fierce rivalry between the market’s most notable players each time an end-date approaches.

That is how L’Oreal was able to poach the Valentino license from Puig (and before that, how Puig nabbed it from Rpoctor & Gamble), after all, and how Euroitalia recently snagged Dsquared2 from fragrance licensor ICR, following a 12-year deal.

Licensed products, such as eyewear and fragrances, which are sold at much lower price points than a designer dress, for instance, serve as a way for brands to court potential new customers and expand into product categories that they may not be equipped to explore in-house. Maybe more importantly, though, they serve as significant sources of revenue.

To put such deals into perspective: As of last year, about 90 percent of the $160 million a year in sales at Calvin Klein Inc. comes from licensing the designer’s name to makers of underwear, jeans and perfume, making licensing an especially effective tool for fashion houses, especially those whose price points are simply too exorbitant for the average consumer.

In much the same way as the acquisitions of fashion brands by big-name conglomerates is head-line making material, so, too is the landing of fashion licensing deals and for good reason. 

[/et_pb_text][/et_pb_column] [/et_pb_row] [/et_pb_section]

related articles